CEO of Immune Pharmaceuticals Inc (IMNP, Financial) Daniel Gedeon Teper bought 937,500 shares of IMNP on 08/04/2016 at an average price of $0.38 a share. The total cost of this purchase was $356,250.
Immune Pharmaceuticals Inc is a clinical stage biopharmaceutical company specializing in the development and commercialization of targeted therapeutics for the treatment of inflammatory diseases and cancer. Immune Pharmaceuticals Inc has a market cap of $13.513 million; its shares were traded at around $0.33 .
CEO Recent Trades:
- CEO, 10% Owner Daniel Gedeon Teper bought 937,500 shares of IMNP stock on 08/04/2016 at the average price of $0.38.
Directors and Officers Recent Trades:
- EVP & CMO Monica E. Luchi bought 777,778 shares of IMNP stock on 08/04/2016 at the average price of $0.45.
- Director Daniel Kazado bought 666,667 shares of IMNP stock on 08/04/2016 at the average price of $0.45.
For the complete insider trading history of IMNP, click here
.
